English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

1 Tutor, Department of Pharmacology, Sri Krishna Medical College, Muzaffarpur 2 Professor & HOD, Department of Pharmacology, Sri Krishna Medical College, Muzaffarpur 3 Associate Professor, Department of Pharmacology, Sri Krishna Medical College, Muzaffarpur *Corresponding Author Dr Gaurav Tiwari Tutor, Department of Pharmacology, Sri Krishna Medical College, Muzaffarpur, India Abstract Objective: Present Randomized controlled trial study was undertaken to evaluate the difference in outcome of patients treated with oral co-amoxyclav, intravenous co-amoxyclav, followed by oral cephalosporins for lower respiratory tract infection. Materials and Methods: A total of 234 patients admitted for lower respiratory tract infection were included in the study. All the patients were randomized in three study Groups. Group A included 75 patients, Group B contains 75 patients and Group C contains 68 patients, 16 patients were excluded from the study. Group A patients received coamoxyclav 500mg/125mg orally three times a day for seven days, Group B patients received 1000mg/200mg intravenously two times a day for three days followed by orally 500mg/125mg three times a day for two days and Group C received cephalosporins 1000mg intravenously two times a day for three days followed by 500 mg orally two times a day for two days. Written consent was taken from all the patients and all the data regarding age, occupation, clinical illness, past history of treatment were noted. Results: There were no significant differences between the all the groups in clinical outcome or mortality. However, patients randomized to oral co-amoxyclav had a significantly shorter hospital stay than the two groups given intravenous antibiotics. Conclusion: Oral antibiotics in lower respiratory tract infection are at least as efficacious as intravenous therapy. Oral antibiotics were cheaper, easier to administer, and may lead to earlier discharge from hospital. Kewwords: Community acquired, Antibiotics, coAmoxyclav, Cephalosporins. Lower respiratory tract infection.

journal of medical science and clinical research

Comparative Study of Oral Co-Amoxyclav versus Intravenous Antibiotics for the Treatment of Community Acquired Lower Respiratory Tract Infection in Tertiary Care Hospital at Muzaffarpur, Bihar